These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 19393685

  • 1. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis.
    Kipp M, Beyer C.
    Front Neuroendocrinol; 2009 Jul; 30(2):188-200. PubMed ID: 19393685
    [Abstract] [Full Text] [Related]

  • 2. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids.
    El-Etr M, Ghoumari A, Sitruk-Ware R, Schumacher M.
    Maturitas; 2011 Jan; 68(1):47-51. PubMed ID: 21035281
    [Abstract] [Full Text] [Related]

  • 3. Astrocytes as targets for neuroprotective drugs.
    Darlington CL.
    Curr Opin Investig Drugs; 2005 Jul; 6(7):700-3. PubMed ID: 16044665
    [Abstract] [Full Text] [Related]

  • 4. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD.
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoids in the control of neuroinflammation.
    Tischner D, Reichardt HM.
    Mol Cell Endocrinol; 2007 Sep 15; 275(1-2):62-70. PubMed ID: 17555867
    [Abstract] [Full Text] [Related]

  • 6. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS, Chen YY, Shang XF, Zhu ZG, Chen GQ, Han Z, Shao B, Yang HM, Xu HQ, Chen JF, Zheng RY.
    Brain Res; 2009 Feb 09; 1253():198-209. PubMed ID: 19083996
    [Abstract] [Full Text] [Related]

  • 7. Future neuroprotective strategies.
    Sättler MB, Bähr M.
    Exp Neurol; 2010 Sep 09; 225(1):40-7. PubMed ID: 19716365
    [Abstract] [Full Text] [Related]

  • 8. Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender.
    Kipp M, Amor S, Krauth R, Beyer C.
    Front Neuroendocrinol; 2012 Jan 09; 33(1):1-16. PubMed ID: 22289667
    [Abstract] [Full Text] [Related]

  • 9. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H, Cudrici C, Niculescu F, Shin ML.
    J Neuroimmunol; 2006 Nov 09; 180(1-2):9-16. PubMed ID: 16905199
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective agents: cannabinoids.
    Sánchez AJ, García-Merino A.
    Clin Immunol; 2012 Jan 09; 142(1):57-67. PubMed ID: 21420365
    [Abstract] [Full Text] [Related]

  • 11. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D.
    Immunopharmacol Immunotoxicol; 2009 Jan 09; 31(1):32-8. PubMed ID: 18792835
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J, Damoiseaux J, Menheere P, Hupperts R.
    J Neuroimmunol; 2008 Feb 09; 194(1-2):7-17. PubMed ID: 18177949
    [Abstract] [Full Text] [Related]

  • 13. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A.
    Expert Rev Neurother; 2008 Sep 09; 8(9):1355-66. PubMed ID: 18759548
    [Abstract] [Full Text] [Related]

  • 14. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
    Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A, Berente Z, Komoly S, Beyer C.
    Glia; 2009 Jun 09; 57(8):807-14. PubMed ID: 19031445
    [Abstract] [Full Text] [Related]

  • 15. [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].
    Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C.
    Rev Neurol; 2009 Jun 09; 43(9):541-8. PubMed ID: 17072810
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective actions of sex steroids in Parkinson's disease.
    Bourque M, Dluzen DE, Di Paolo T.
    Front Neuroendocrinol; 2009 Jul 09; 30(2):142-57. PubMed ID: 19410597
    [Abstract] [Full Text] [Related]

  • 17. Oestrogen and progestins differently prevent glutamate toxicity in cortical neurons depending on prior hormonal exposure via the induction of neural nitric oxide synthase.
    Mannella P, Sanchez AM, Giretti MS, Genazzani AR, Simoncini T.
    Steroids; 2009 Aug 09; 74(8):650-6. PubMed ID: 19463685
    [Abstract] [Full Text] [Related]

  • 18. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R, Arnon R.
    Drug News Perspect; 2009 Aug 09; 22(6):301-12. PubMed ID: 19771319
    [Abstract] [Full Text] [Related]

  • 19. Chemokines and disease.
    Gerard C, Rollins BJ.
    Nat Immunol; 2001 Feb 09; 2(2):108-15. PubMed ID: 11175802
    [Abstract] [Full Text] [Related]

  • 20. Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies.
    Simpkins JW, Yang SH, Wen Y, Singh M.
    Cell Mol Life Sci; 2005 Feb 09; 62(3):271-80. PubMed ID: 15723163
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.